l-carnitine tmao nature medicine 2013 koeth γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to l carnitine tmao nature medicine
l carnitine tmao nature medicine 2013 koeth Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Cardiovascular risk of dietary trimethylamine Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Meat metabolizing bacteria in atherosclerosis Nature Medicine Trimethylamine N Oxide and Related Gut Microbe Derived Metabolites and Incident Heart Failure Development in Community Based Populations Circulation: Heart Failure A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





